{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:30:33Z","timestamp":1790836233936,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Commonly attributed to the prevalence of M2 macrophages, tumor-associated macrophages (TAM) are linked to poor outcome in Hodgkin lymphoma (HL). MYC is supposed to control the expression of M2-specific genes in macrophages, and deficiency in MYC-positive macrophages inhibits tumor growth in mouse models. To verify this hypothesis for HL, seventy-six samples were subjected to immunohistochemical double staining using CD68 or CD163 macrophage-specific antibodies and a reagent detecting MYC. For each cell population, labelled cells were grouped according to low, intermediate and high numbers and related to disease-free survival (DFS) and overall survival (OS). MYC+ cells accounted for 21% and 18% of CD68+ and CD163+ cells, respectively. Numbers of MYC\u2212 macrophages were significantly higher in EBV+ cases while no differences were observed for MYC+ macrophages between EBV+ and EBV\u2212 cases.\u00a0Cases with highest numbers of macrophages usually showed worst DFS and OS. In most scenarios, intermediate numbers of macrophages were associated with better outcome than very low or very high numbers. Our observations are reminiscent of the \u201chormesis hypothesis\u201d and suggest that a relative lack of TAM may allow HL growth while macrophages display an inhibitory effect with increasing numbers. Above a certain threshold, TAM may again support tumor growth.<\/jats:p>","DOI":"10.1038\/s41598-020-66010-z","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T10:03:15Z","timestamp":1591783395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome"],"prefix":"10.1038","volume":"10","author":[{"given":"Laura","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Henrique M.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"B\u00fcttner-Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Grittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Niedobitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"66010_CR1","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo, E. et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117, 5019\u20135032, https:\/\/doi.org\/10.1182\/blood-2011-01-293050 (2011).","journal-title":"Blood"},{"key":"66010_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0140-6736(03)12777-8","volume":"361","author":"L Yung","year":"2003","unstructured":"Yung, L. & Linch, D. Hodgkin\u2019s lymphoma. Lancet 361, 943\u2013951, https:\/\/doi.org\/10.1016\/S0140-6736(03)12777-8 (2003).","journal-title":"Lancet"},{"key":"66010_CR3","doi-asserted-by":"publisher","unstructured":"Xu, M. L. & Fedoriw, Y. Lymphoma microenvironment and immunotherapy. Surg. Pathol. Clin. 9, 93\u2013100, https:\/\/doi.org\/10.1016\/j.path.2015.10.001 (2016).","DOI":"10.1016\/j.path.2015.10.001"},{"key":"66010_CR4","doi-asserted-by":"publisher","unstructured":"Ruella, M. et al. Overcoming the immunosuppressive tumor microenvironment of Hodgkin lymphoma using chimeric antigen receptor T cells. Cancer Discov. 7, 1154\u20131167, https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0850 (2017).","DOI":"10.1158\/2159-8290.CD-16-0850"},{"key":"66010_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","volume":"22","author":"A Mantovani","year":"2010","unstructured":"Mantovani, A. & Sica, A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231\u2013237, https:\/\/doi.org\/10.1016\/j.coi.2010.01.009 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"66010_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-59745-396-7_3","volume":"531","author":"A Classen","year":"2009","unstructured":"Classen, A., Lloberas, J. & Celada, A. Macrophage activation: classical versus alternative. Methods Mol. Biol. 531, 29\u201343, https:\/\/doi.org\/10.1007\/978-1-59745-396-7_3 (2009).","journal-title":"Methods Mol. Biol."},{"key":"66010_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1189\/jlb.0504272","volume":"76","author":"RD Stout","year":"2004","unstructured":"Stout, R. D. & Suttles, J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509\u2013513, https:\/\/doi.org\/10.1189\/jlb.0504272 (2004).","journal-title":"J. Leukoc. Biol."},{"key":"66010_CR8","doi-asserted-by":"publisher","first-page":"342","DOI":"10.4049\/jimmunol.175.1.342","volume":"175","author":"RD Stout","year":"2005","unstructured":"Stout, R. D. et al. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342\u2013349, https:\/\/doi.org\/10.4049\/jimmunol.175.1.342 (2005).","journal-title":"J. Immunol."},{"key":"66010_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536\u2013541, https:\/\/doi.org\/10.1038\/415536a (2002).","journal-title":"Nature"},{"key":"66010_CR10","doi-asserted-by":"publisher","first-page":"5952","DOI":"10.4049\/jimmunol.164.11.5952","volume":"164","author":"C Chizzolini","year":"2000","unstructured":"Chizzolini, C., Rezzonico, R., De Luca, C., Burger, D. & Dayer, J. M. Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes. J. Immunol. 164, 5952\u20135960, https:\/\/doi.org\/10.4049\/jimmunol.164.11.5952 (2000).","journal-title":"J. Immunol."},{"key":"66010_CR11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1189\/jlb.72.1.101","volume":"72","author":"CF Anderson","year":"2002","unstructured":"Anderson, C. F. & Mosser, D. M. A novel phenotype for an activated macrophage: the type 2 activated macrophage. J. Leukoc. Biol. 72, 101\u2013106 (2002).","journal-title":"J. Leukoc. Biol."},{"key":"66010_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell Jr.","year":"1994","unstructured":"Darnell, J. E. Jr., Kerr, I. M. & Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415\u20131421, https:\/\/doi.org\/10.1126\/science.8197455 (1994).","journal-title":"Science"},{"key":"66010_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nri3088","volume":"11","author":"T Lawrence","year":"2011","unstructured":"Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750\u2013761, https:\/\/doi.org\/10.1038\/nri3088 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"66010_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677\u2013686, https:\/\/doi.org\/10.1016\/j.it.2004.09.015 (2004).","journal-title":"Trends Immunol."},{"key":"66010_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein, M., Keshav, S., Harris, N. & Gordon, S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287\u2013292, https:\/\/doi.org\/10.1084\/jem.176.1.287 (1992).","journal-title":"J. Exp. Med."},{"key":"66010_CR16","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.4049\/jimmunol.169.10.5715","volume":"169","author":"S Cao","year":"2002","unstructured":"Cao, S. et al. Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma. J. Immunol. 169, 5715\u20135725, https:\/\/doi.org\/10.4049\/jimmunol.169.10.5715 (2002).","journal-title":"J. Immunol."},{"key":"66010_CR17","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.4049\/jimmunol.172.12.7565","volume":"172","author":"AL Pauleau","year":"2004","unstructured":"Pauleau, A. L. et al. Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 172, 7565\u20137573, https:\/\/doi.org\/10.4049\/jimmunol.172.12.7565 (2004).","journal-title":"J. Immunol."},{"key":"66010_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl, C. et al. Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma. N. Engl. J. Med. 362, 875\u2013885, https:\/\/doi.org\/10.1056\/NEJMoa0905680 (2010).","journal-title":"N. Engl. J. Med."},{"key":"66010_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1677\/ERC-08-0036","volume":"15","author":"M Ryder","year":"2008","unstructured":"Ryder, M., Ghossein, R. A., Ricarte-Filho, J. C., Knauf, J. A. & Fagin, J. A. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr. Relat. Cancer 15, 1069\u20131074, https:\/\/doi.org\/10.1677\/ERC-08-0036 (2008).","journal-title":"Endocr. Relat. Cancer"},{"key":"66010_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1167\/iovs.10-5979","volume":"52","author":"IH Bronkhorst","year":"2011","unstructured":"Bronkhorst, I. H. et al. Detection of M2-macrophages in uveal melanoma and relation with survival. Invest. Ophthalmol. Vis. Sci. 52, 643\u2013650, https:\/\/doi.org\/10.1167\/iovs.10-5979 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"66010_CR21","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/j.1349-7006.2010.01614.x","volume":"101","author":"H Hasita","year":"2010","unstructured":"Hasita, H. et al. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Cancer Sci. 101, 1913\u20131919, https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01614.x (2010).","journal-title":"Cancer Sci."},{"key":"66010_CR22","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","volume":"167","author":"H Kurahara","year":"2011","unstructured":"Kurahara, H. et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J. Surg. Res. 167, e211\u2013219, https:\/\/doi.org\/10.1016\/j.jss.2009.05.026 (2011).","journal-title":"J. Surg. Res."},{"key":"66010_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","volume":"196","author":"L Bingle","year":"2002","unstructured":"Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254\u2013265, https:\/\/doi.org\/10.1002\/path.1027 (2002).","journal-title":"J. Pathol."},{"key":"66010_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1200\/JCO.2005.12.172","volume":"23","author":"JJ Chen","year":"2005","unstructured":"Chen, J. J. et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J. Clin. Oncol. 23, 953\u2013964, https:\/\/doi.org\/10.1200\/JCO.2005.12.172 (2005).","journal-title":"J. Clin. Oncol."},{"key":"66010_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica, A., Schioppa, T., Mantovani, A. & Allavena, P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717\u2013727, https:\/\/doi.org\/10.1016\/j.ejca.2006.01.003 (2006).","journal-title":"Eur. J. Cancer"},{"key":"66010_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1182\/blood-2011-02-339911","volume":"119","author":"OM Pello","year":"2012","unstructured":"Pello, O. M. et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 119, 411\u2013421, https:\/\/doi.org\/10.1182\/blood-2011-02-339911 (2012).","journal-title":"Blood"},{"key":"66010_CR27","doi-asserted-by":"publisher","first-page":"e45399","DOI":"10.1371\/journal.pone.0045399","volume":"7","author":"OM Pello","year":"2012","unstructured":"Pello, O. M. et al. In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities. PLoS One 7, e45399, https:\/\/doi.org\/10.1371\/journal.pone.0045399 (2012).","journal-title":"PLoS One"},{"key":"66010_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/path.1711660102","volume":"166","author":"PG Murray","year":"1992","unstructured":"Murray, P. G., Young, L. S., Rowe, M. & Crocker, J. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin\u2019s disease. J. Pathol. 166, 1\u20135, https:\/\/doi.org\/10.1002\/path.1711660102 (1992).","journal-title":"J. Pathol."},{"key":"66010_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.177.2.339","volume":"177","author":"EM Deacon","year":"1993","unstructured":"Deacon, E. M. et al. Epstein-Barr virus and Hodgkin\u2019s disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 177, 339\u2013349, https:\/\/doi.org\/10.1084\/jem.177.2.339 (1993).","journal-title":"J. Exp. Med."},{"key":"66010_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-j","volume":"337","author":"G Pallesen","year":"1991","unstructured":"Pallesen, G., Hamilton-Dutoit, S. J., Rowe, M. & Young, L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease. Lancet 337, 320\u2013322, https:\/\/doi.org\/10.1016\/0140-6736(91)90943-j (1991).","journal-title":"Lancet"},{"key":"66010_CR31","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1002\/ijc.27314","volume":"131","author":"MH Barros","year":"2012","unstructured":"Barros, M. H., Vera-Lozada, G., Soares, F. A., Niedobitek, G. & Hassan, R. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection. Int. J. Cancer 131, 1142\u20131152, https:\/\/doi.org\/10.1002\/ijc.27314 (2012).","journal-title":"Int. J. Cancer"},{"key":"66010_CR32","doi-asserted-by":"publisher","first-page":"e0124531","DOI":"10.1371\/journal.pone.0124531","volume":"10","author":"MH Barros","year":"2015","unstructured":"Barros, M. H., Segges, P., Vera-Lozada, G., Hassan, R. & Niedobitek, G. Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival. PLoS One 10, e0124531, https:\/\/doi.org\/10.1371\/journal.pone.0124531 (2015).","journal-title":"PLoS One"},{"key":"66010_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1046\/j.1365-2141.2002.03815.x","volume":"119","author":"GL Stark","year":"2002","unstructured":"Stark, G. L. et al. Hodgkin\u2019s disease in the elderly: a population-based study. Br. J. Haematol. 119, 432\u2013440, https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03815.x (2002).","journal-title":"Br. J. Haematol."},{"key":"66010_CR34","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1182\/blood-2004-09-3759","volume":"106","author":"RF Jarrett","year":"2005","unstructured":"Jarrett, R. F. et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 106, 2444\u20132451, https:\/\/doi.org\/10.1182\/blood-2004-09-3759 (2005).","journal-title":"Blood"},{"key":"66010_CR35","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1200\/JCO.2008.20.5138","volume":"27","author":"A Diepstra","year":"2009","unstructured":"Diepstra, A. et al. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin\u2019s lymphoma predicts adverse outcome in older adult patients. J. Clin. Oncol. 27, 3815\u20133821, https:\/\/doi.org\/10.1200\/JCO.2008.20.5138 (2009).","journal-title":"J. Clin. Oncol."},{"key":"66010_CR36","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.humpath.2013.06.006","volume":"44","author":"CS Tudor","year":"2013","unstructured":"Tudor, C. S. et al. B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction. Hum. Pathol. 44, 2475\u20132486, https:\/\/doi.org\/10.1016\/j.humpath.2013.06.006 (2013).","journal-title":"Hum. Pathol."},{"key":"66010_CR37","doi-asserted-by":"publisher","first-page":"e80908","DOI":"10.1371\/journal.pone.0080908","volume":"8","author":"MH Barros","year":"2013","unstructured":"Barros, M. H., Hauck, F., Dreyer, J. H., Kempkes, B. & Niedobitek, G. Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One 8, e80908, https:\/\/doi.org\/10.1371\/journal.pone.0080908 (2013).","journal-title":"PLoS One"},{"key":"66010_CR38","unstructured":"RCore Team R: A language and environment for statistical computing. Vienna, Austria, R Foundation for Statistical Computing (2019)."},{"key":"66010_CR39","unstructured":"Therneau, T. M. & Lumley, T. Package \u2018survival\u2019. CRAN, The Comprehensive R Archive Network (2019)."},{"key":"66010_CR40","volume-title":"Modeling survival data: extending the Cox model.","author":"TM Therneau","year":"2013","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling survival data: extending the Cox model. (Springer Science & Business Media, New York, 2013)."},{"key":"66010_CR41","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin\u2010Gadda, H. Estimating and comparing time\u2010dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397, https:\/\/doi.org\/10.1002\/sim.5958 (2013).","journal-title":"Stat. Med."},{"key":"66010_CR42","unstructured":"Eklund, A. Beeswarm: The bee swarm plot, an alternative to stripchart. R package version 0.2.3 (2016)."},{"key":"66010_CR43","doi-asserted-by":"publisher","first-page":"e114345","DOI":"10.1371\/journal.pone.0114345","volume":"9","author":"CS Tudor","year":"2014","unstructured":"Tudor, C. S. et al. Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphoma. PLoS One 9, e114345, https:\/\/doi.org\/10.1371\/journal.pone.0114345 (2014).","journal-title":"PLoS One"},{"key":"66010_CR44","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3109\/10428194.2011.580026","volume":"52","author":"LR Jakovic","year":"2011","unstructured":"Jakovic, L. R. et al. The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma. Leuk. Lymphoma 52, 1913\u20131919, https:\/\/doi.org\/10.3109\/10428194.2011.580026 (2011).","journal-title":"Leuk. Lymphoma"},{"key":"66010_CR45","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3109\/10428194.2013.778405","volume":"54","author":"L Panico","year":"2013","unstructured":"Panico, L. et al. Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma. Leuk. Lymphoma 54, 2418\u20132425, https:\/\/doi.org\/10.3109\/10428194.2013.778405 (2013).","journal-title":"Leuk. Lymphoma"},{"key":"66010_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000321567","volume":"77","author":"A Tzankov","year":"2010","unstructured":"Tzankov, A., Matter, M. S. & Dirnhofer, S. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma. Pathobiology 77, 301\u2013308, https:\/\/doi.org\/10.1159\/000321567 (2010).","journal-title":"Pathobiology"},{"key":"66010_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3324\/haematol.2010.031542","volume":"96","author":"P Kamper","year":"2011","unstructured":"Kamper, P. et al. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin\u2019s lymphoma. Haematologica 96, 269\u2013276, https:\/\/doi.org\/10.3324\/haematol.2010.031542 (2011).","journal-title":"Haematologica"},{"key":"66010_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1600-0609.2011.01731.x","volume":"88","author":"DH Yoon","year":"2012","unstructured":"Yoon, D. H. et al. CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma. Eur. J. Haematol. 88, 292\u2013305, https:\/\/doi.org\/10.1111\/j.1600-0609.2011.01731.x (2012).","journal-title":"Eur. J. Haematol."},{"key":"66010_CR49","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","volume":"120","author":"KL Tan","year":"2012","unstructured":"Tan, K. L. et al. Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood 120, 3280\u20133287, https:\/\/doi.org\/10.1182\/blood-2012-04-421057 (2012).","journal-title":"Blood"},{"key":"66010_CR50","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/annonc\/mdr157","volume":"23","author":"D Azambuja","year":"2012","unstructured":"Azambuja, D. et al. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin\u2019s lymphoma. Ann. Oncol. 23, 736\u2013742, https:\/\/doi.org\/10.1093\/annonc\/mdr157 (2012).","journal-title":"Ann. Oncol."},{"key":"66010_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1746-1596-7-12","volume":"7","author":"JA Harris","year":"2012","unstructured":"Harris, J. A. et al. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma. Diagn. Pathol. 7, 12, https:\/\/doi.org\/10.1186\/1746-1596-7-12 (2012).","journal-title":"Diagn. Pathol."},{"key":"66010_CR52","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3324\/haematol.2011.055459","volume":"97","author":"B Sanchez-Espiridion","year":"2012","unstructured":"Sanchez-Espiridion, B. et al. Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin\u2019s lymphoma. Haematologica 97, 1080\u20131084, https:\/\/doi.org\/10.3324\/haematol.2011.055459 (2012).","journal-title":"Haematologica"},{"key":"66010_CR53","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00428-011-1140-8","volume":"459","author":"MA Zaki","year":"2011","unstructured":"Zaki, M. A. et al. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch. 459, 361\u2013366, https:\/\/doi.org\/10.1007\/s00428-011-1140-8 (2011).","journal-title":"Virchows Arch."},{"key":"66010_CR54","doi-asserted-by":"crossref","unstructured":"Pettersen, J. S. et al. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 131, 1322\u20131330, https:\/\/doi.org\/10.103\/jid.2011.9 (2011).","DOI":"10.1038\/jid.2011.9"},{"key":"66010_CR55","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","volume":"113","author":"B Chetaille","year":"2009","unstructured":"Chetaille, B. et al. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113, 2765\u20133775, https:\/\/doi.org\/10.1182\/blood-2008-07-168096 (2009).","journal-title":"Blood"},{"key":"66010_CR56","doi-asserted-by":"publisher","unstructured":"Comi, M. et al. Coexpression of CD163 and CD141 identifies human circulating IL-10-producing dendritic cells (DC-10). Cell. Mol. Immunol. 17, 95\u2013107, https:\/\/doi.org\/10.1038\/s41423-019-0218-0 (2020).","DOI":"10.1038\/s41423-019-0218-0"},{"key":"66010_CR57","doi-asserted-by":"publisher","unstructured":"Enblad, G. et al. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin\u2019s disease. Int. J. Cancer\u00a072, 394\u2013397, https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970729)72:3<394::aid-ijc3>3.0.co;2-k (1997).","DOI":"10.1002\/(sici)1097-0215(19970729)72:3<394::aid-ijc3>3.0.co;2-k"},{"key":"66010_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/jcp.53.3.182","volume":"53","author":"M Engel","year":"2000","unstructured":"Engel, M. et al. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin\u2019s lymphoma: study of 47 South African cases. J. Clin. Pathol. 53, 182\u2013186, https:\/\/doi.org\/10.1136\/jcp.53.3.182 (2000).","journal-title":"J. Clin. Pathol."},{"key":"66010_CR59","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","volume":"23","author":"TH Keegan","year":"2005","unstructured":"Keegan, T. H. et al. Epstein-Barr virus as a marker of survival after Hodgkin\u2019s lymphoma: a population-based study. J. Clin. Oncol. 23, 7604\u20137613, https:\/\/doi.org\/10.1200\/JCO.2005.02.6310 (2005).","journal-title":"J. Clin. Oncol."},{"key":"66010_CR60","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1158\/1078-0432.CCR-12-0129","volume":"18","author":"MH Barros","year":"2012","unstructured":"Barros, M. H., Hassan, R. & Niedobitek, G. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact. Clin. Cancer Res. 18, 3762\u20133771, https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0129 (2012).","journal-title":"Clin. Cancer Res."},{"key":"66010_CR61","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1126\/science.176.4031.170","volume":"176","author":"RT Prehn","year":"1972","unstructured":"Prehn, R. T. The immune reaction as a stimulator of tumor growth. Science 176, 170\u2013171, https:\/\/doi.org\/10.1126\/science.176.4031.170 (1972).","journal-title":"Science"},{"key":"66010_CR62","doi-asserted-by":"publisher","unstructured":"Prehn, R. T. The initial immune reaction to a new tumor antigen is always stimulatory and probably necessary for the tumor\u2019s growth. Clin. Dev. Immunol. 2010, https:\/\/doi.org\/10.1155\/2010\/851728 (2010).","DOI":"10.1155\/2010\/851728"},{"key":"66010_CR63","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1073\/pnas.1209067111","volume":"111","author":"OM Pearce","year":"2014","unstructured":"Pearce, O. M. et al. Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc. Natl Acad. Sci. USA 111, 5998\u20136003, https:\/\/doi.org\/10.1073\/pnas.1209067111 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66010-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66010-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:08:56Z","timestamp":1670328536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66010-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66010-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"24 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9410"}}